Type to search

Bioscience and pharmaceutical Education Insider Only News Technology & IT

NIIMBL receives $83M to tackle vaccine development

Avatar photo
Share

NEWARK – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) was recently awarded $153 million in new funding from its federal partners, including $83 million specifically to work on coronavirus-related projects. “Obviously, there's an element of COVID-19, but also a big part of it is how we make sure we never have this happen

Want to Read More?

Paid DBT subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.

Become an Insider Now

Already an Insider? Log In.

Tags:

You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *

Premier Digital Partners

© 2024 Delaware Business Times

Flash Sale! Subscribe to Delaware Business Times and save 50%.

Limited time offer. New subscribers only.

Limited time offer. New subscribers only.

SUMMER FLASH SALE!

Subscribe to Delaware Business Times and save 50%